Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson’s disease
暂无分享,去创建一个
[1] B. Bhushan,et al. Persistent organic pollutants in foods, their interplay with gut microbiota and resultant toxicity. , 2022, The Science of the total environment.
[2] T. Milewicz,et al. Differences in the Composition of Gut Microbiota between Patients with Parkinson’s Disease and Healthy Controls: A Cohort Study , 2021, Journal of clinical medicine.
[3] K. Ohno,et al. Altered gut microbiota in Parkinson's disease patients with motor complications. , 2021, Parkinsonism & related disorders.
[4] J. Raes,et al. Temporal variability in quantitative human gut microbiome profiles and implications for clinical research , 2021, Nature Communications.
[5] B. B. Finlay,et al. Gut microbiome in Parkinson's disease: New insights from meta-analysis. , 2021, Parkinsonism & related disorders.
[6] Liangwei Mao,et al. Cross-Sectional Study on the Gut Microbiome of Parkinson’s Disease Patients in Central China , 2021, Frontiers in Microbiology.
[7] Zachary D. Wallen,et al. Exploring human-genome gut-microbiome interaction in Parkinson’s disease , 2021, NPJ Parkinson's disease.
[8] Gangduo Wang,et al. Gut microbiome-host interactions in driving environmental pollutant trichloroethene-mediated autoimmunity. , 2021, Toxicology and applied pharmacology.
[9] D. Berg,et al. Gut microbiome signatures of risk and prodromal markers of Parkinson's disease. , 2021, Annals of neurology.
[10] K. Murros,et al. Desulfovibrio Bacteria Are Associated With Parkinson’s Disease , 2021, Frontiers in Cellular and Infection Microbiology.
[11] B. Racette,et al. Solvent exposed occupations and risk of Parkinson disease in Finland , 2021, Clinical parkinsonism & related disorders.
[12] I. Charles,et al. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation , 2021, NPJ Parkinson's disease.
[13] B. D. De Miranda,et al. The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease , 2020, Neurobiology of Disease.
[14] C. Rajput,et al. Is Gut Dysbiosis an Epicenter of Parkinson’s Disease? , 2021, Neurochemical Research.
[15] Wei Chen,et al. Blautia—a new functional genus with potential probiotic properties? , 2021, Gut microbes.
[16] Irving E. Vega,et al. Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease , 2021, Metabolites.
[17] K. Murros. Sulfate reducing gut bacteria and Parkinson's disease , 2020, European journal of neurology.
[18] K. Gokulan,et al. Sex-Dependent Effects on Liver Inflammation and Gut Microbial Dysbiosis After Continuous Developmental Exposure to Trichloroethylene in Autoimmune-Prone Mice , 2020, Frontiers in Pharmacology.
[19] Cuidan Li,et al. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. , 2020, Parkinsonism & related disorders.
[20] Irving E. Vega,et al. Gut microbiome dysbiosis is associated with elevated toxic bile acids in Parkinson’s disease , 2020, bioRxiv.
[21] Lanjuan Li,et al. Alterations of the Human Gut Microbiome in Chronic Kidney Disease , 2020, Advanced science.
[22] N. Pedersen,et al. Clostridium difficile infection and risk of Parkinson's disease: a Swedish population‐based cohort study , 2020, European journal of neurology.
[23] Ronan M. T. Fleming,et al. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions , 2020, BMC Biology.
[24] Zhaobo Chen,et al. Trichloroethylene inhibits nitrogen transformation and microbial community structure in Mollisol , 2020, Ecotoxicology.
[25] B. Zheng,et al. Distribution characteristics and health risk assessment of volatile organic compounds in the groundwater of Lanzhou City, China , 2020, Environmental Geochemistry and Health.
[26] Zachary D. Wallen,et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens , 2020, npj Parkinson's Disease.
[27] H. Weiner,et al. The sex-specific interaction of the microbiome in neurodegenerative diseases , 2019, Brain Research.
[28] B. Zhu,et al. Analysis of the Gut Microflora in Patients With Parkinson's Disease , 2019, Front. Neurosci..
[29] L. Moulin,et al. Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans , 2019, BMC Genomics.
[30] Guohong Cui,et al. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China , 2019, Front. Mol. Neurosci..
[31] E. Chuang,et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease , 2019, Journal of Neuroinflammation.
[32] Rachael V. Phillips,et al. Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer , 2019, Epigenetics.
[33] E. Pekkonen,et al. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression , 2019, EBioMedicine.
[34] G. Diamond,et al. Toxicological profile for trichloroethylene (TCE) , 2019 .
[35] C. Sue,et al. Parkinson’s disease and the gastrointestinal microbiome , 2019, Journal of Neurology.
[36] C. Consolandi,et al. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism , 2018, Movement disorders : official journal of the Movement Disorder Society.
[37] M. Ota,et al. Bifidobacterium and Lactobacillus Counts in the Gut Microbiota of Patients With Bipolar Disorder and Healthy Controls , 2019, Front. Psychiatry.
[38] K. Gokulan,et al. Irreversible effects of trichloroethylene on the gut microbial community and gut‐associated immune responses in autoimmune‐prone mice , 2018, Journal of applied toxicology : JAT.
[39] Hongwei Zhou,et al. Gut microbiota in patients with Parkinson's disease in southern China. , 2018, Parkinsonism & related disorders.
[40] J. Jeong,et al. Trichloroethylene and Parkinson’s Disease: Risk Assessment , 2018, Molecular Neurobiology.
[41] M. Mohajeri,et al. Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases , 2018, Nutrients.
[42] B. Pakkenberg,et al. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 , 2018, Gut.
[43] Chunyan Wu,et al. Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease , 2018, Brain, Behavior, and Immunity.
[44] A. Heintz‐Buschart,et al. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.
[45] James T. Morton,et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome , 2017, Movement disorders : official journal of the Movement Disorder Society.
[46] Luis Pedro Coelho,et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.
[47] V. Govorun,et al. Analysis of Gut Microbiota in Patients with Parkinson’s Disease , 2017, Bulletin of Experimental Biology and Medicine.
[48] F. Guarino,et al. Use of Zea mays L. in phytoremediation of trichloroethylene , 2017, Environmental Science and Pollution Research.
[49] M. Tansey,et al. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? , 2017, npj Parkinson's Disease.
[50] R. Colwell,et al. Enrichment dynamics of Listeria monocytogenes and the associated microbiome from naturally contaminated ice cream linked to a listeriosis outbreak , 2016, BMC Microbiology.
[51] K. Fassbender,et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.
[52] I. Rusyn,et al. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps , 2016, The Journal of Pharmacology and Experimental Therapeutics.
[53] D. Dalvie,et al. Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics , 2016, Drug Metabolism and Disposition.
[54] R. Colwell,et al. Cross-talk among flesh-eating Aeromonas hydrophila strains in mixed infection leading to necrotizing fasciitis , 2016, Proceedings of the National Academy of Sciences.
[55] K. Ohno,et al. Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease , 2015, PloS one.
[56] Ali Keshavarzian,et al. Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[57] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[58] Rob Knight,et al. Longitudinal analysis of microbial interaction between humans and the indoor environment , 2014, Science.
[59] Rita R. Colwell,et al. Microbial Community Profiling of Human Saliva Using Shotgun Metagenomic Sequencing , 2014, PloS one.
[60] J. Schnoor,et al. Biodegradation of mono-hydroxylated PCBs by Burkholderia xenovorans , 2012, Biotechnology Letters.
[61] C. Tanner,et al. Solvent exposures and parkinson disease risk in twins , 2012, Annals of neurology.
[62] G. Bing,et al. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats , 2010, Journal of neurochemistry.
[63] Sara Khan,et al. Effect of trichloroethylene (TCE) toxicity on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in kidney and other rat tissues. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[64] N. Hisanaga,et al. Occupational trichloroethylene exposure as a cause of idiosyncratic generalized skin disorders and accompanying hepatitis similar to drug hypersensitivities , 2007, International archives of occupational and environmental health.
[65] D. Putt,et al. Metabolism and Tissue Distribution of Orally Administered Trichloroethylene in Male and Female Rats: Identification of Glutathione- and Cytochrome P-450-Derived Metabolites in Liver, Kidney, Blood, and Urine , 2006, Journal of toxicology and environmental health. Part A.
[66] G. Sakorafas,et al. Hepatitis caused by occupational chronic exposure to trichloroethylene. , 2004, Acta gastro-enterologica Belgica.
[67] C. Paulu,et al. Tetrachloroethylene-contaminated drinking water in Massachusetts and the risk of colon-rectum, lung, and other cancers. , 1999, Environmental health perspectives.
[68] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[69] 한범수,et al. Trichloroethylene , 1994, Reactions Weekly.
[70] J. Gossett,et al. Biological reductive dechlorination of tetrachloroethylene and trichloroethylene to ethylene under methanogenic conditions , 1989, Applied and environmental microbiology.
[71] A. Keshavarzian,et al. The gut microbiome in Parkinson's disease: A culprit or a bystander? , 2020, Progress in brain research.
[72] K. Shannon,et al. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. , 2017, Journal of Parkinson's disease.
[73] Iarc Monographs,et al. TRICHLOROETHYLENE, TETRACHLOROETHYLENE, AND SOME OTHER CHLORINATED AGENTS. , 2014, IARC monographs on the evaluation of carcinogenic risks to humans.
[74] F. Sitas. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (incl Sitas F.) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens , 2011 .